Compelo Medical Devices - Latest industry news and analysis is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More

Syneron Medical buys Ultrashape

Syneron Medical, a provider of aesthetic devices, has finalized the acquisition of Ultrashape.

Ultrashape is involved in developing and manufacturing of non-invasive technologies for fat cell destruction and body sculpting.

Syneron said now Ultrashape’s products, which are approved in Europe, Canada, Latin America and Asia, will now be available through its worldwide network of direct and distributor sales channels.

Syneron Medical CEO Louis Scafuri said Ultrashape’s technology provides a differentiated, physician and patient friendly, non-invasive treatment for de-bulking and body sculpting of normal to overweight patients.

"We are very excited to welcome the Ultrashape team to Syneron and look forward to working with them to begin our US clinical trial and continue broadening global exposure for this important technology," Scafuri added.